Gland Pharma Limited (NSE: GLAND)
India flag India · Delayed Price · Currency is INR
1,906.00
+14.20 (0.75%)
Sep 6, 2024, 3:29 PM IST

Gland Pharma Company Description

Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.

The company engages in research and development of pharmaceutical active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules.

The company offers its products for various therapeutic categories, such as anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastrointestinal, gynaecological, hormones, neuro/Cns, ophthal/otological, and other areas, as well as pain and analgesics, respiratory, and vitamins, minerals, and nutrients; and contract development services.

The company was incorporated in 1978 and is headquartered in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.

Gland Pharma Limited
Country India
Founded 1978
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 4,217
CEO Srinivas Sadu

Contact Details

Address:
Plot No. 11 & 84, TSIIC Phase: IV
Hyderabad, 502307
India
Phone 91 84 5569 9999
Website glandpharma.com

Stock Details

Ticker Symbol GLAND
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE068V01023
SIC Code 2834

Key Executives

Name Position
Srinivas Sadu Chief Executive Officer and Executive Chairman
Ravi Shekhar Mitra Chief Financial Officer
Sampath Kumar Pallerlamudi Company Secretary and Vice-President of Compliance & CSR
Satnam Singh Loomba Chief Operating Officer
Ankit Gupta Head of Investments, Strategy and Investor Relations
Surinder Koul Head of Domestic Marketing
Dr. Surapanini Sridevi Senior Vice President of Research & Development
K Raghuramachandra Rao Head of Quality
Rong Wu Chief Financial Controller